{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:09:59Z","timestamp":1779304199647,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020272","name":"Hungarian Society of Hypertension","doi-asserted-by":"publisher","award":["TSGH-SS_E_113016"],"award-info":[{"award-number":["TSGH-SS_E_113016"]}],"id":[{"id":"10.13039\/501100020272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001526","name":"Wellington City Council","doi-asserted-by":"publisher","award":["TSGH-SS_E_113018"],"award-info":[{"award-number":["TSGH-SS_E_113018"]}],"id":[{"id":"10.13039\/501100001526","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-D-113"],"award-info":[{"award-number":["MND-MAB-D-113"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-D-113170"],"award-info":[{"award-number":["MND-MAB-D-113170"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MND-MAB-D-112145"],"award-info":[{"award-number":["MND-MAB-D-112145"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-B-112020"],"award-info":[{"award-number":["TSGH-B-112020"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-SS_E_112012"],"award-info":[{"award-number":["TSGH-SS_E_112012"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-D-112093"],"award-info":[{"award-number":["TSGH-D-112093"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH-SS_E_112013"],"award-info":[{"award-number":["TSGH-SS_E_112013"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010425","name":"Tri-Service General Hospital","doi-asserted-by":"publisher","award":["TSGH_D_113102"],"award-info":[{"award-number":["TSGH_D_113102"]}],"id":[{"id":"10.13039\/501100010425","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Diabetes and its Complications"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jdiacomp.2024.108898","type":"journal-article","created":{"date-parts":[[2024,10,25]],"date-time":"2024-10-25T06:52:07Z","timestamp":1729839127000},"page":"108898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pioglitazone increases risk of ischemic heart disease in patients with type 2 diabetes receiving insulin"],"prefix":"10.1016","volume":"38","author":[{"given":"Ming-Hang","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wu-Chien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-Chung","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi-Hsiang","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lih-Chyang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo-Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsin-An","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdiacomp.2024.108898_bb0005","series-title":"The Global Impact of Diabetes","author":"Federation IID","year":"2019"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0010","doi-asserted-by":"crossref","first-page":"778","DOI":"10.2337\/db12-0073","article-title":"Insulin resistance and type 2 diabetes","volume":"61","author":"Taylor","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0015","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Emerging Risk Factors C","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0020","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0025","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1093\/eurheartj\/eht149","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I","volume":"34","author":"Paneni","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0030","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0035","first-page":"65","article-title":"A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. V. Evaluation of pheniformin therapy","volume":"24","author":"The University Group Diabetes Program","year":"1975","journal-title":"Diabetes"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0040","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0045","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of Hyperglycemia in Type 2 Diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0050","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00125-017-4499-5","article-title":"Lower risk of dementia with pioglitazone, compared with other second-line treatments, in metformin-based dual therapy: a population-based longitudinal study","volume":"61","author":"Lu","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0055","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1001\/jama.298.10.1180","article-title":"Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials","volume":"298","author":"Lincoff","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124287","article-title":"Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, all in combination with metformin, for type 2 diabetes: a population-based cohort study","volume":"10","author":"Seong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0065","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/liv.14714","article-title":"Thiazolidinediones were associated with higher risk of cardiovascular events in patients with type 2 diabetes and cirrhosis","volume":"41","author":"Yen","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0070","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/17571472.2010.11493315","article-title":"An overview of the healthcare system in Taiwan","volume":"3","author":"Wu","year":"2010","journal-title":"London J Prim Care (Abingdon)"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0075","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0895-4356(92)90133-8","article-title":"Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases","volume":"45","author":"Deyo","year":"1992","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0080","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0085","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0090","doi-asserted-by":"crossref","first-page":"6527820","DOI":"10.1155\/2020\/6527820","article-title":"The role of gender in the importance of risk factors for coronary artery disease","volume":"2020","author":"Gheisari","year":"2020","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0095","doi-asserted-by":"crossref","first-page":"10268","DOI":"10.1038\/s41598-022-14472-8","article-title":"Chronic kidney disease is a key predictive factor for potential myocardial ischaemia and poor prognosis in asymptomatic patients with diabetes mellitus","volume":"12","author":"Honda","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0100","doi-asserted-by":"crossref","first-page":"358","DOI":"10.35772\/ghm.2020.01113","article-title":"Cardiovascular disease, a major global burden: epidemiology of stroke and ischemic heart disease in Japan","volume":"3","author":"Iso","year":"2021","journal-title":"Glob Health Med"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12933-015-0300-6","article-title":"Adverse cardiovascular outcomes between insulin-treated and non-insulin treated diabetic patients after percutaneous coronary intervention: a systematic review and meta-analysis","volume":"14","author":"Bundhun","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S2213-8587(18)30315-2","volume":"7","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0115","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.3909\/ricm0671","article-title":"Divergent effects of various diabetes drugs on cardiovascular prognosis","volume":"14","author":"Bell","year":"2013","journal-title":"Rev Cardiovasc Med"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0120","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00125-009-1558-6","article-title":"Mitogenic action of insulin: friend, foe or \u2018frenemy\u2019?","volume":"53","author":"Draznin","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0125","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.jacc.2008.03.051","article-title":"Effect of diabetes on progression of coronary atherosclerosis and arterial remodeling: a pooled analysis of 5 intravascular ultrasound trials","volume":"52","author":"Nicholls","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0130","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.5551\/jat.30007","article-title":"Effects of pioglitazone for secondary stroke prevention in patients with impaired glucose tolerance and newly diagnosed diabetes: the J-SPIRIT study","volume":"22","author":"Tanaka","year":"2015","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0135","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0140","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz026","article-title":"Pioglitazone exposure reduced the risk of all-cause mortality in insulin-treated patients with type 2 diabetes mellitus","volume":"105","author":"Yen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0145","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1111\/j.1463-1326.2008.00892.x","article-title":"Pioglitazone and cardiovascular risk. A comprehensive meta-analysis of randomized clinical trials","volume":"10","author":"Mannucci","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0150","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/dme.12800","article-title":"Cardiovascular risks associated with second-line oral antidiabetic agents added to metformin in patients with Type 2 diabetes: a nationwide cohort study","volume":"32","author":"Chang","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0155","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1056\/NEJMoa072761","article-title":"Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes","volume":"356","author":"Nissen","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0160","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2217\/14750708.4.5.517","article-title":"Pioglitazone in the management of Type 2 diabetes and beyond","volume":"4","author":"Sourij","year":"2007","journal-title":"Therapy"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0165","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.diabres.2006.09.010","article-title":"Thiazolidinediones and the risk of edema: a meta-analysis","volume":"76","author":"Berlie","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0170","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.therap.2021.10.002","article-title":"Reappraisal of the efficacy of intensive glycaemic control on microvascular complications in patients with type 2 diabetes: a meta-analysis of randomised control-trials","volume":"77","author":"Sun","year":"2022","journal-title":"Therapie"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0175","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.2337\/dc20-2439","article-title":"Historical HbA(1c) values may explain the type 2 diabetes legacy effect: UKPDS 88","volume":"44","author":"Lind","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jdiacomp.2024.108898_bb0180","article-title":"Pioglitazone for prevention or delay of type 2 diabetes mellitus and its associated complications in people at risk for the development of type 2 diabetes mellitus","volume":"11","author":"Ipsen","year":"2020","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Journal of Diabetes and its Complications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724002241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056872724002241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T11:15:06Z","timestamp":1742037306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056872724002241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1056872724002241"],"URL":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108898","relation":{},"ISSN":["1056-8727"],"issn-type":[{"value":"1056-8727","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pioglitazone increases risk of ischemic heart disease in patients with type 2 diabetes receiving insulin","name":"articletitle","label":"Article Title"},{"value":"Journal of Diabetes and its Complications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108898"}}